SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
G Medical Innovations Holdings Ltd (GMVD) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 12/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
✗
HEALTH
0/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — GMVD
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.00
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.00
Book Value / Share$0.00
Revenue / Share$0.00
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$0.00 |
$0.00 |
$0.00 |
- |
| 2017 |
$-20.39 |
$109K |
$-27.25M |
-24997.2% |
| 2018 |
$-8.60 |
$3.06M |
$-16.98M |
-554.4% |
| 2019 |
$-7.00 |
$5.53M |
$-15.51M |
-280.6% |
| 2020 |
$-60.40 |
$4.9M |
$-12.69M |
-258.9% |
| 2021 |
$-45.89 |
$5.06M |
$-14.89M |
-294.3% |
| 2022 |
$0.00 |
$4.42M |
$-13.96M |
-315.8% |